Lab News Zhongming Zhao Biography Keyword Cloud (click) Latest News: *** Position available: Postdoctoral Fellow in Bioinformatics (click here) *** Our paper entitled "Functional consequences of somatic mutations in cancer using protein pocket-based prioritization approach" appeared in Genome Medicine was Editors' pick (10-17-2014). Media report: "Bradfords' strong support bolsters melanoma research" appeared in the VUMC reporter (09-25-2014) Media report: "VU study reveals shared pathways in psychiatric disorders" appeared in the VUMC reporter (09-18-2014) Our paper entitled "VarWalker: personalized mutation network analysis of putative cancer genes from next-generation sequencing data" was recommended by Faculty 1000 (09-12-2014) Welcome three rotation students: Michaela Fooksa, Hunter Gibbons, and Gregory Salimando! (09-10-2014) Media report: "Drug discovery clues in network map" appeared in the VUMC reporter (08-01-2014) Dr. Sabrina Fritah, a visiting postdoc supported by INTER/MOBILITY Progamme, Luxembourg, arrived our lab. Welcome!(07-28-2014). Santu's paper entitled "Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer" was accepted by RNA. Congratulations, Santu!(05-01-2014). We welcome two new persons: Dr. Francisco Azuaje as a visiting scientist from Luxembourg, and Christen Parzych as our new Program Coordinator. Welcome!(05-01-2014). Our paper entitled "Network-assisted prediction of potential drugs for addiction" was among the ~30 papers selected in AMIA TBI … Continue reading →

MOUNTAIN VIEW, California, January 27, 2015 /PRNewswire/ -- U.S.-based cancer patient advocacy and charitable organization, International Cancer Advocacy Network (ICAN), in collaboration with Finland-based bioinformatics company MediSapiens, announced their intent to launch Remission Coach (patent pending) this year in a presentation at the Personalized Medicine World Conference in Mountain View, California. Remission Coach is a web-based solution that addresses the urgency of cancer management by providing patients with a personalized platform for actively determining the most appropriate clinical trial for that patient's disease and treatment history. According to Robert H. Tamis, M. D., ICAN's Chairman of Health Information Technology Initiatives, "Remission Coach offers a secure, sophisticated, yet easy-to-use electronic interface for patients and their caregivers to safely enter and store clinical information, such as pathology and imaging reports, treatment history, and molecular profiling data. The clinical trials industry and patients will be able to use Remission Coach for immediate access to critical information that will vastly improve and accelerate the recruitment of trial candidates while minimizing the notoriously crippling costs of patient accrual." Only a very small percentage of late-stage cancer patients are informed by their oncology teams about clinical trials. This is not for lack of effort or caring … Continue reading →